{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:25:55Z","timestamp":1779359155139,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2015 Id.17226"],"award-info":[{"award-number":["IG 2015 Id.17226"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione per la ricerca sui tumori dell\u2019apparato muscoloscheletrico e rari Onlus","award":["CRT RF=2016-0917"],"award-info":[{"award-number":["CRT RF=2016-0917"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3262-0","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T22:41:53Z","timestamp":1492036913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Alpha\u2013fetoprotein elevation in NUT midline carcinoma: a case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Lorenzo","family":"D\u2019Ambrosio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Palesandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Carnevale Schianca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Aglietta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5515-569X","authenticated-orcid":false,"given":"Giovanni","family":"Grignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"issue":"8","key":"3262_CR1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/2159-8290.CD-14-0014","volume":"4","author":"CA French","year":"2014","unstructured":"French CA, Rahman S, Walsh EM, K\u00fchnle S, Grayson AR, Lemieux ME, Grunfeld N, Rubin BP, Antonescu CR, Zhang S, et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov. 2014;4(8):928\u201341.","journal-title":"Cancer Discov."},{"issue":"20","key":"3262_CR2","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","volume":"18","author":"DE Bauer","year":"2012","unstructured":"Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, L\u00fcer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012;18(20):5773\u20139.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3262_CR3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrc3659","volume":"14","author":"C French","year":"2014","unstructured":"French C. NUT midline carcinoma. Nat Rev Cancer. 2014;14(3):149\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3262_CR4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011;146(6):904\u201317.","journal-title":"Cell"},{"issue":"2","key":"3262_CR5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12105-013-0479-3","volume":"8","author":"AF Mills","year":"2014","unstructured":"Mills AF, Lanfranchi M, Wein RO, Mukand-Cerro I, Pilichowska M, Cowan J, Bedi H. NUT midline carcinoma: a case report with a novel translocation and review of the literature. Head Neck Pathol. 2014;8(2):182\u20136.","journal-title":"Head Neck Pathol."},{"issue":"6","key":"3262_CR6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.pathol.2016.06.010","volume":"48","author":"S Shatavi","year":"2016","unstructured":"Shatavi S, Fawole A, Haberichter K, Jaiyesimi I, French C. Nuclear protein in testis (NUT) midline carcinoma with a novel three-way translocation (4;15;19)(q13;q14;p13.1). Pathology. 2016;48(6):620\u20133.","journal-title":"Pathology"},{"issue":"6","key":"3262_CR7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jcp.2007.052902","volume":"63","author":"CA French","year":"2010","unstructured":"French CA. Demystified molecular pathology of NUT midline carcinomas. J Clin Pathol. 2010;63(6):492\u20136.","journal-title":"J Clin Pathol"},{"key":"3262_CR8","volume-title":"WHO classification of Tumours: pathology and genetics of Tumours of the urinary system and Male genital organs","author":"JN Eble","year":"2004","unstructured":"Eble JN, Sauter G, Epstein JI, Sesterhenn IA. WHO classification of Tumours: pathology and genetics of Tumours of the urinary system and Male genital organs. Lyon: IARC Press; 2004."},{"issue":"7","key":"3262_CR9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","volume":"33","author":"H Haack","year":"2009","unstructured":"Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, Hong SM, Schwartz BE, Cameron MJ, Rubin MA, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33(7):984\u201391.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3262_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12105-013-0428-1","volume":"7","author":"CA French","year":"2013","unstructured":"French CA. The importance of diagnosing NUT midline carcinoma. Head Neck Pathol. 2013;7(1):11\u20136.","journal-title":"Head Neck Pathol"},{"issue":"2","key":"3262_CR11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1066896912451651","volume":"21","author":"W Fang","year":"2013","unstructured":"Fang W, French CA, Cameron MJ, Han Y, Liu H. Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract. Int J Surg Pathol. 2013;21(2):102\u201310.","journal-title":"Int J Surg Pathol"},{"key":"3262_CR12","volume-title":"WHO classification of Tumours of the lung, pleura, thymus and heart","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO classification of Tumours of the lung, pleura, thymus and heart. Lyon: International Agency for Research on Cancer; 2015."},{"issue":"1","key":"3262_CR13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1186\/s12885-016-2944-3","volume":"16","author":"Y Harada","year":"2016","unstructured":"Harada Y, Koyama T, Takeuchi K, Shoji K, Hoshi K, Oyama Y. NUT midline carcinoma mimicking a germ cell tumor: a case report. BMC Cancer. 2016;16(1):895.","journal-title":"BMC Cancer"},{"key":"3262_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gynor.2012.09.004","volume":"3","author":"A Ball","year":"2012","unstructured":"Ball A, Bromley A, Glaze S, French CA, Ghatage P, K\u00f6bel M. A rare case of NUT midline carcinoma. Gynecol Oncol Case Rep. 2012;3:1\u20133.","journal-title":"Gynecol Oncol Case Rep"},{"issue":"10","key":"3262_CR15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/JTO.0b013e3182a00f41","volume":"8","author":"SA Parikh","year":"2013","unstructured":"Parikh SA, French CA, Costello BA, Marks RS, Dronca RS, Nerby CL, Roden AC, Peddareddigari VG, Hilton J, Shapiro GI, et al. NUT midline carcinoma: an aggressive intrathoracic neoplasm. J Thorac Oncol. 2013;8(10):1335\u20138.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"3262_CR16","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1586\/14737140.2015.1082909","volume":"15","author":"A Raza","year":"2015","unstructured":"Raza A, Cao H, Conrad R, Cobb C, Castelino-Prabhu S, Mirshahidi S, Shiraz P, Mirshahidi HR. Nuclear protein in testis midline carcinoma with unusual elevation of \u03b1-fetoprotein and synaptophysin positivity: a case report and review of the literature. Expert Rev Anticancer Ther. 2015;15(10):1199\u2013213.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"6","key":"3262_CR17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2303.2010.00838.x","volume":"22","author":"B Zhu","year":"2011","unstructured":"Zhu B, Laskin W, Chen Y, French CA, Cameron MJ, Nayar R, Lin X. NUT midline carcinoma: a neoplasm with diagnostic challenges in cytology. Cytopathology. 2011;22(6):414\u20137.","journal-title":"Cytopathology"},{"key":"3262_CR18","unstructured":"BioGPS, http:\/\/biogps.org\/ . Accessed 1 Feb 2017."},{"issue":"19","key":"3262_CR19","doi-asserted-by":"crossref","first-page":"17698","DOI":"10.18632\/oncotarget.4131","volume":"6","author":"MM Coud\u00e9","year":"2015","unstructured":"Coud\u00e9 MM, Braun T, Berrou J, Dupont M, Bertrand S, Masse A, Raffoux E, Itzykson R, Delord M, Riveiro ME, et al. BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells. Oncotarget. 2015;6(19):17698\u2013712.","journal-title":"Oncotarget"},{"issue":"5","key":"3262_CR20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/2159-8290.CD-15-1335","volume":"6","author":"A Stathis","year":"2016","unstructured":"Stathis A, Zucca E, Bekradda M, Gomez-Roca C, Delord JP, de La Motte RT, Uro-Coste E, de Braud F, Pelosi G, French CA. Clinical response of carcinomas harboring the BRD4-NUT Oncoprotein to the targeted Bromodomain inhibitor OTX015\/MK-8628. Cancer Discov. 2016;6(5):492\u2013500.","journal-title":"Cancer Discov"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3262-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:46:47Z","timestamp":1498387607000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3262-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3262"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3262-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]},"article-number":"266"}}